Fundraising Fox

Canaan Partners β€” 2014 Investments

11 investments dated 2014 Β· listed companies and verified rows first Β· show all

CytomX TherapeuticsNASDAQ: CTMXDec 2014SEC filingmedium confidence

Clinical-stage biotechnology company developing conditionally activated, masked biologics designed to be localized to the tumor microenvironment.

BiotechSouth San Francisco, US

Sean McCarthy(Executive Officer, Director)

BoardElaine V. Jones(Director)Neil Exter(Director)inFrederick W. Gluck(Director)Hoyoung Huh(Director)

Board seatTim ShannonΒ· per SEC Form D Β· $30M raise Β· filed Jan 2015

Co-investorsLongitude CapitalThird Rock Ventures

Fast LabsMar 2014SEC filingmedium confidence

Marina Del Rey, US

Matt Munson(Executive Officer, Director)

BoardMat Ellis(Director)Wyatt Jenkins(Director)

Board seatMaha IbrahimΒ· per SEC Form D Β· $18M raise Β· filed Jun 2018

Transcend MedicalMar 2014

Menlo Park, US

Board seatWende HuttonΒ· per SEC Form D

Co-investorsLightstone Ventures

Apartment Listapartmentlist.comin𝕏Dec 2014

Apartment List operates an online rental marketplace that uses a quiz-based AI matching system to connect renters with apartments that fit their preferences and lifestyle.

AI & Machine LearningMarketplacesPropTechSan Francisco, US

John Douglas Kobs II(Executive Officer, Director)Charles Christopher Herndon(Executive Officer, Director)John Kobs(Founder)Chris Erickson(Co-founder)

BoardJosh Hannah(Director)Dana Stalder(Director)in

Co-investorsAndre IguodalaAUTHENTIC VENTURESGlynn Capital ManagementMatrixTenaya CapitalTribeca Early Stage Partners+3 more

Civitas Therapeuticscivitastherapeutics.comAug 2014

BiotechChelsea, US

ROB HOPFNER(Director)BLAIR JACKSON(Director)BRYAN STUART(Executive Officer)TIMOTHY S. NELSON(Director)RAJEEV SHAH(Director)MARK IWICKI(Executive Officer, Director)

Co-investorsSofinnova VenturesBay City CapitalLongitude CapitalOrbiMedRA Capital

Compstakcompstak.comin𝕏Oct 2014

CompStak is a crowdsourced commercial real estate data platform that aggregates millions of data points weekly to provide comprehensive CRE datasets for lenders, investors, and landlords.

Data & InfrastructureEnterprise SoftwarePropTechNew York, US

Michael Mandel(Co-founder & CEO)inVadim Belobrovka(Co-founder & CTO)Hrach Simonian(Director)Una Una Mitrovic

Co-investors500 GlobalCamber CreekEscalate Capital PartnersExpansion Venture CapitalFounder CollectiveGlobal Brain+4 more

Esperion Therapeuticsesperion.comJun 2014

BiotechAnn Arbor, US

Antonio M. Gotto, Jr.(Director)Tim M. Mayleben(Executive Officer, Director)Gilbert S. Omenn(Director)Daniel Janney(Director)Dov A. Goldstein(Director)Nicole Vitullo(Director)

Co-investorsAisling CapitalAlta PartnersArboretum VenturesARCHIMED JapanAsset Management CompanyLongitude Capital+2 more

MoviePassmoviepass.comin𝕏Jun 2014

MoviePass is a movie subscription service that also operates Mogul, a prediction market and fantasy league for film and entertainment.

ConsumerGamingMedia & EntertainmentSaaSNew York

Stacy Spikes(Co-Founder)inHamet Watt(Director)Christopher Kelly(Director)

Co-investorsLightship CapitalClaritas CapitalElevate Innovation PartnersEvolution VC PartnersZenStone Venture CapitalAnimoca Brands+4 more

Novira TherapeuticsDec 2014

BiotechDoylestown, US

Anthony Ford-Hutchinson(Director)Daniel E. Geffken(Executive Officer)Tim Shannon(Director)Osvaldo Flores(Executive Officer, Director)George Hartman(Executive Officer)Gregory Korbel(Executive Officer)

Co-investorsBioAdvance5AM VenturesVersant Ventures

Spinifex PharmaceuticalsApr 2014

BiotechStamford

Tom McCarthy(President, CEO, Secretary & Treasurer)Christopher Nave(Director)Heath Lukatch(Director)Brent Ahrens(Director)Stephen Collins(Director)Joshua Funder(Director)

ZugataDec 2014Acquired

Palo Alto SaaS company offering AI-driven continuous peer feedback and performance development, acquired by Culture Amp in 2019.

Palo Alto, US

Srinivas Krishnamurti(Executive Officer, Director)Philippe Van Nuijs(Executive Officer, Director)

Co-investorsGeneral CatalystRedpoint Ventures

Rows marked β€œSEC filing” are inferred from directors named on the company's SEC Form D β€” public regulatory data, not a portfolio list published by the firm.